Intermountain Healthcare has developed a new method for estimating outcomes for patients with chronic obstructive pulmonary disease. The Laboratory-based Intermountain Validated Exacerbation (LIVE) score is a prediction model that predicts all-cause mortality, morbidity, and hospitalization rates for patients with COPD, a chronic, progressive lung disease that gradually makes it hard to breathe. In the study, Intermountain Healthcare researchers calculated LIVE scores of 17,124 COPD patients from the Kaiser Health System Northwest Region. They found that patients with high-risk LIVE scores had the highest one-year mortality rates (39.4 percent) and the highest rate of palliative care referrals (41.7 percent). In comparison, patients with the lowest risk LIVE scores had 0.7 percent all cause one-year mortality and 0.7 percent palliative care referral rate.
Making Health Care Better
The Alliance of Community Health Plans is a national leadership organization bringing together innovative health plans and provider groups that are among America’s best at delivering affordable, high-quality coverage and care. Our plans are shaping the future of health care - driving better health outcomes, building healthier communities and inspiring an entire industry to do better.